Nicox S.A. (EPA:ALCOX)
France
· Delayed Price · Currency is EUR 0.439
-0.011 (-2.34%)
Mar 9, 2026, 5:35 PM CET
Nicox Revenue
Nicox had revenue of 1.53M EUR in the half year ending June 30, 2025, with 6.72% growth. This brings the company's revenue in the last twelve months to 3.32M, down -63.45% year-over-year. In the year 2024, Nicox had annual revenue of 7.86M with 13.84% growth.
Revenue (ttm)
3.32M
Revenue Growth
-63.45%
P/S Ratio
11.95
Revenue / Employee
663.16K
Employees
5
Market Cap
39.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.86M | 955.64K | 13.84% |
| Dec 31, 2023 | 6.90M | 3.63M | 111.04% |
| Dec 31, 2022 | 3.27M | -3.96M | -54.78% |
| Dec 31, 2021 | 7.23M | -5.67M | -43.96% |
| Dec 31, 2020 | 12.91M | 6.05M | 88.29% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fermentalg | 12.78M |
| THX Pharma Société Anonyme | 876.13K |
| Advicenne | 5.90M |
| Valerio Therapeutics Société anonyme | 1.83M |
| genOway Société anonyme | 27.16M |
| GenSight Biologics | 945.00K |
| OSE Immunotherapeutics | 1.78M |
| Aelis Farma | 2.33M |